Huber Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$1.15M Buy
15,072
+1,294
+9% +$110K 0.43% 28
2019
Q4
$1.22M Buy
13,778
+8
+0.1% +$664 0.42% 33
2019
Q3
$1.04M Sell
13,770
-303
-2% -$20.8K 0.41% 33
2019
Q2
$1.02M Sell
14,073
-87
-0.6% -$6.84K 0.44% 30
2019
Q1
$1.14M Sell
14,160
-629
-4% -$51.5K 0.56% 24
2018
Q4
$1.36M Sell
14,789
-3,245
-18% -$285K 0.74% 20
2018
Q3
$1.71M Buy
18,034
+5,417
+43% +$514K 1.31% 14
2018
Q2
$1.17M Buy
12,617
+4,895
+63% +$478K 1.07% 17
2018
Q1
$731K Buy
7,722
+1,459
+23% +$160K 0.72% 26
2017
Q4
$606K Buy
+6,263
New +$590K 0.67% 27

Other funds holding ABBV

Huber Financial Advisors's ABBV Position: Q1 2020 in Review

Huber Financial Advisors increased its AbbVie (ABBV) stake by 9.4% in Q1 2020, buying an estimated $110K and bringing the position to 15,072 shares worth $1.15M. The position accounts for 0.43% of the portfolio, ranked #28.

Huber Financial Advisors first reported a position in ABBV in Q4 2017 and has held it in 10 quarters since. The position peaked at $1.71M in Q3 2018. 2,226 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • Huber Financial Advisors held 15,072 shares of AbbVie worth $1.15M as of Q1 2020.
  • Huber Financial Advisors bought 1,294 AbbVie shares in Q1 2020, an estimated $110K.
  • AbbVie made up 0.43% of Huber Financial Advisors's portfolio in Q1 2020, its #28 holding.
  • Huber Financial Advisors first reported a position in AbbVie in Q4 2017 and has held it in 10 quarters since.
  • Huber Financial Advisors's AbbVie position peaked at $1.71M in Q3 2018.
  • 2,226 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Huber Financial Advisors's 13F filing for Q1 2020, filed 17 Apr 2020.